It really makes me sad that I made a 5 paragraph post trying to explain this then yahoo didnt allow it to post nor saved my data...I hate yahoo boards
I'm just going to step in here, although I still feel that most people here are immature, it could help for me to provide insight.
There are several companies, hundreds or more, that do this every day, dostoyevsky.
The first example revolves around companies that advertise antioxidants. The theory, is that free radicals steal electrons from atoms, imbalancing molecules, therefore causing aging, cancers, etc.
*Numerous* tests have been done to test antioxidants, it is estimated over 100,000 people have been utilized among all the antioxidant surveys, labs, etc.
The findings? Antioxidants have had no proof of helping people live longer, and has in fact if anything, shown to potentially cause early cancer in some patients.
Yet, you see antioxidant commercials everywhere.
Fruit diets? Yes, another marketing thing utilized by many companies to state how a fruit diet can help you. Findings? It has increased the chances of pancreatic cancer. Remember the beloved Steve Jobs and his love of fruits for daily nutrition? He died of pancreatic cancer. When Ashton Kutcher even attempted the diet to fulfill the role of Steve Jobs in the previously released movie, he had been hospitalized for pancreatic issues. Yet, many companies offer their fruit diets to consumers as a coy.
Fact is, companies do this, a lot. For someone to sue the company over this, it would take years of research in court to determine the company's lie resulted in your early cancer or prevented it. It is too difficult to prove and takes too long. Hence, lack of regulatory arrangements in this industry, as well as too high of a cost for people to bother sueing.
If history doesn't repeat itself, that makes the whole theory of resistance/support selling/buying thrown out the window, which is arguably one of the most utilized entry strategies for non-corporate buyers.
I have been in and out of CBIS for years. It is currently being pumped, literally provable by the stock promoters website where you can search by ticker, they're recently been utilizing newsletters to pump. CBIS has diluted over and over, since their balance sheet often has balances in the low thousands, even 0. This company does NOT have money, they pump, then dilute, and dump. Believe me when I say it is very difficult to be profitable with 750+ million shares. This could very well go up to $.20 for all I know, but it will come tumbling down at some point again. Look at the history. Good luck.
No one knows for sure, but much of the consensus seems to be that they might have had a large deposit after the possible of increase of 2 bil to 4 bil authorized shares and are now being investigated since there doesnt seem to have been an advance notice as there typically is
TBH, INO's main claim is their DNA vaccine, but there has yet to be a successful DNA vaccine that made it through all the FDA trials. It's promising but historically risky. More focus if anything, should be placed on their other products.
Can be one of several things, but it's definitely revolving around technical trades. Same thing happened to YMI well before they were bought out by GMCR. A spike is hit after a series of PR pumps (regardless of validity), then traders bring it down based on rules such as fibonacci retracement, support/resistance points, etc. It's a biotech, all of them go through this. It's unfortunate but it's life
You probably have the ability to do market order or stop limit order. I unfortunately do not as I am cheap and don't like to pay for the more expensive platforms. Nonetheless, I changed my order to execute at .19. I'm all in, hello to everybody again :)
LOL. I have been preaching this same thing for 4 years. CBIS IS a scam, but know what? I still invest in it. It is one of the most well known scam stocks out there, but people buy it all the time due to hype, etc. It's a wonderful stock, because if you play cards right, you make bank. They dillute like it's their job, and each time they do, they pump like crazy. I just bought back into this stock yesterday. Although I feel it will still go down to .036 first, I feel I can at least make a good 20% on it no problem on the next pump. Many people don't invest here because they believe in the company, only a few on this board do. Otherwise, most well know that this company means nothing.
Not really. Unfortunately a buyout would cost another company, at bare minimum, 103 million with the market cap. The downside to that company that would buy them, is that YGYI made negative income of 430,000 last year, and this past quarter only about 1 million. Therefore, at a 103+ mil buyout, the buying company (at this rate) would have to wait about 25 years just to get that income back, or based on the year income, they'd never get it back. There's too much discrepancy in the numbers for it to be a SAFE bet that another company would buy them. That doesn't mean, however, that it couldn't happen. Another company might see something about YGYI that is easily fixable, but a conversative company would most likely stay away.
For me it's the short term risk that I care about. I dont play long term stocks at all anymore, I just no longer have the patience because to me that minimizes cash flow opportunity. But for anyone that can play long, it should be highly rewarding, yes.
with prices where they are now, any hype seems to send this thing temporarily soaring. I read back on a few posts about people saying it's not a pump and dump, which is fine, but it is kind of needed. Such a low market cap is not attractive to more investors
Hey masscoach1. Glad to see you discovered INO, I played with them a bit ago around .50s to .70s. INO has some of the most impressive, market leading ability to revolutionize vaccine immunizations through higher efficacy, cheaper methods and an overall great approach to vaccines for serious illnesses including sexually related.
In my personal opinion, INO is very volatile at this point since much of their work is still phase I, and bio companies need to make it to stage 3 before even attempting approval, let alone some do stage 4. Fact is, they may not have enough cash to fund themselves up to that point, and may require a dilution soon. I also backed out of INO a long time ago due to heavy manipulation of daytrading. Long term, it's a phenomenal opportunity, probably a 10x bagger. But, in the interim, I may not jump in until I see a pullback, only based on my own risk/reward situation. But, of course, it still may move up and I miss an opportunity. My own theory is it's best to play it safe and not lose/regret it, than to gamble on hopes and lose what you could have kept or grown slowly but at a safer gain.
Best of luck to you either way.